KEYNOTE-604: Phase 3 trial of pembrolizumab plus etoposide/platinum (EP) for first-line treatment of extensive stage small-cell lung cancer (ES-SCLC) Meeting Abstract


Authors: Rudin, C. M.; Shen, L.; Pietanza, M. C.
Abstract Title: KEYNOTE-604: Phase 3 trial of pembrolizumab plus etoposide/platinum (EP) for first-line treatment of extensive stage small-cell lung cancer (ES-SCLC)
Meeting Title: 42nd ESMO Congress (ESMO 2017)
Journal Title: Annals of Oncology
Volume: 28
Issue: Suppl. 5
Meeting Dates: 2017 Sep 8-12
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2017-09-01
Start Page: mdx386.008
Language: English
ACCESSION: WOS:000411324004004
PROVIDER: wos
DOI: 10.1093/annonc/mdx386.008
Notes: Meeting Abstract: 1535TiP -- Appears on page 541 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles Rudin
    488 Rudin